Prostate cancer risk in pre-diabetic men: A matched cohort study

Clinical Medicine and Research

Volumn 11, Issue 4, 2013, Pages 201-209

  Onitilo, Adedayo A ^a,b   Berg, Richard L ^a   Engel, Jessica M ^a   Stankowski, Rachel V ^a   Glurich, Ingrid ^a   Williams, Gail M ^b   Doi, Suhail A R ^b  

^a MARSHFIELD CLINIC   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

NNEH NNEB; Prostatic neoplasms epidemiology; Risk factors; Type 2 diabetes mellitus

Indexed keywords

NNEH/NNEB; PROSTATIC NEOPLASMS/EPIDEMIOLOGY; RISK FACTORS; TYPE 2 DIABETES MELLITUS;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; RISK FACTORS; TIME FACTORS;

EID: 84893551967     PISSN: 15394182     EISSN: 15546179     Source Type: Journal    
DOI: 10.3121/cmr.2013.1160     Document Type: Article

References (30)

1. Onitilo AA, Engel JM, Glurich I, Stankowski RV, Williams GM, Doi SA. Diabetes and cancer I: risk, survival, and implications for screening. Cancer Causes Control 2012;23:967-981.
2. Bansal D, Bhansali A, Kapil G, Undela K, Tiwari P. Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies. Prostate Cancer Prostatic Dis 2013;16:151-158 S1. doi:10.1038/pcan.2012.40. Epub 2012 Oct 2.
3. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Diabetes mellitus and risk of prostate cancer (United States). Cancer Causes Control 1998;9:3-9.
4. Wang C, Jackson G, Jones TH, Matsumoto AM, Nehra A, Perelman MA, Swerdloff RS, Traish A, Zitzmann M, Cunningham G. Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes. Diabetes Care 2011;34:1669-1675.
5. Goto A, Morita A, Goto M, Sasaki S, Miyachi M, Aiba N, Terauchi Y, Noda M, Watanabe S. Associations of sex hormone-binding globulin and testosterone with diabetes among men and women (the Sake Diabetes study): a case control study. Cardiovasc Diabetol 2012;11:130.
6. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006;295: 1288-1299.
7. Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MK. Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 1996;87:570-574.
8. N. Prostate carcinogenesis with diabetes and androgen-deprivation-therapy-related diabetes: an update. Exp Diabetes Res 2012:801610.
9. Tavani A, Gallus S, Bosetti C, Tzonou A, Lagiou P, Negri E, Trichopoulos D, La Vecchia C. Diabetes and the risk of prostate cancer. Eur J Cancer Prev 2002;11:125-128.
10. Rodriguez C, Patel AV, Mondul AM, Jacobs EH, Thun M, Calle EE. Diabetes and risk of prostate cancer in a prospective cohort of US men. Am J Epidemiol 2005;161:147-152.
11. Calton BA, Chang SC, Wright ME, Kipnis V, Lawson K, Thompson FE, Subar AF, Mouw T, Campbell DS, Hurwitz P, Hollenbeck A, Schatzkin A, Leitzmann MF. History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study. Cancer Causes Control 2007;18:493-503.
12. Kasper JS, Liu Y, Giovannucci E. Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study. Int J Cancer 2009;124:1398-1403.
13. Atchison EA, Gridley G, Carreon JD, Leitzmann MF, McGlynn KA. Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer 2011;128:635-643.
14. Pierce BL, Plymate S, Ostrander EA, Standford JL. Diabetes mellitus and prostate cancer risk. Prostate 2008;68: 1126-1132.
15. Turner EL, Lane JA, Donovan JL, Davis MJ, Metcalfe C, Neal DE, Hamdy FC, Martin RM. Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study). Int J Cancer 2011;128:440-446.
16. Tseng CH. Diabetes and risk of prostate cancer: a study using the National Health Insurance. Diabetes Care 2011;34: 616-621.
17. Onitilo AA, Engel JM, Greenlee RT, Mukesh BN. Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival. Clin Med Res 2009;7:4-13.
18. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33:S62-S69.
19. DeStefano F, Eaker ED, Broste SK, Nordstrom DL, Peissig PL, Vierkant RA, Konitzer KA, Gruber RL, Layde PM. Epidemiologic research in an integrated regional medical care system: the Marshfield Epidemiologic Study Area. J Clin Epidemiol 1996;49:643-652.
20. De Lemos MLNNT for studies with long-term follow-up. CMAJ 2005;172:613-615.
21. Kaplan SA, Meehan AG, Shah A. The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men? J Urol. 2006;176:1524-1527; discussion 1527-528.
22. George JT, Veldhuis JD, Tena-Sempere M, Millar RP, Anderson RA. Exploring the pathophysiology of hypogonadism in men with type 2 diabetes: kisspeptin-10 stimulates serum testosterone and LH secretion in men with type 2 diabetes and mild biochemical hypogonadism. Clin Endocrinol (Oxf) 2013;79:100-104. doi:10.1111/cen.12103. Epub 2013 Apr 19.
23. Grossmann M, Thomas MC, Panagiotopoulos S, Sharpe K, Macisaac RJ, Clarke S, Zajac JD, Jerums G. Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab 2008;93:1834-1840.
24. Kasper JS, Liu Y, Pollak MN, Rifai N, Giovannucci E. Hormonal profile of diabetic men and the potential link to prostate cancer. Cancer Causes Control 2008;19:703-710.
25. Baradaran N, AHmadi H, Salem S, Lotfi M, Jahani Y, Baradaran N, Mehrsai AR, Pourmand G. The protective effect of diabetes mellitus against prostate cancer: role of sex hormones. Prostate 2009;69:1744-1750.
26. Lee MY, Lin KD, Hsiao PJ, Shin SJ. The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients. Metabolism 2012;62:242-249.
27. Long XJ, Lin S, Sun YN, Zheng ZF. Diabetes mellitus and prostate cancer risk in Asian countries: a meta-analysis. Asian Pac J Cancer Prev 2012;13:4097-4100.
28. Moreira DM, Anderson T, Gerber L, Thomas JA, Bañez LL, McKeever MG, Hoyo C, Grant D, Jayachandran J, Freedland SJ. The association of diabetes mellitus and high-grade prostate cancer in a multiethnic biopsy series. Cancer Causes Control 2011;22:977-983.
29. Fukushima H, Masuda H, Kawakami S, Ito M, Sakura M, Numao N, Koga F, Saito K, Fujii Y, Yamamoto S, Yonese J, Fukui I, Kihara K. Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL. Urology 2012;79:1329-1334.
30. Cheetham P, Truesdale M, Chaudhury S, Wenske S, Hruby GW, Katz Aheetham. Long-term cancer-specific and overall survival for men followed more than 10 years after primary and salvage cryoablation of the prostate. J Endourol 2010;24:1123-1129.